Table 3.
Bioequivalence analysis (confidence interval [CI] 80.00–125.00)
| Parameter | Units | Ratio % | Classical 90% CI (test/reference) | |
|---|---|---|---|---|
| Lower 90% CI | Upper 90% CI | |||
| Cmax | pg/ml | 94.18 | 74.83 | 118.55 |
| AUC0-t | h*pg/ml | 121.71 | 106.86 | 138.61 |
| AUC0-inf | h*pg/ml | 121.63 | 106.73 | 138.62 |
| AUC0-2 h | h*pg/ml | 105.59 | 90.82 | 122.77 |
| AUC2-11h | h*pg/ml | 165.92 | 137.11 | 200.78 |
AUC0-2 h area under the time versus drug concentration curve from hour 0 to hour 2 post-administration, AUC2-11h area under the time versus drug concentration curve from hour 2 to 11 post-administration, AUC0inf area under the time versus drug concentration curve from 0 to infinity, AUC0-t area under the time versus drug concentration curve from 0 to the last observation calculated according to the linear trapezoidal rule, Cmax observed maximum plasma drug concentration